JunD reduces tumor angiogenesis by protecting cells from oxidative stress

Cell

Volumn 118, Issue 6, 2004, Pages 781-794

  Gerald, Damien ^a   Berra, Edurne ^b   Frapart, Yves M ^c   Chan, Denise A ^d   Giaccia, Amato J ^d   Mansuy, Daniel ^c   Pouysségur, Jacques ^b   Yaniv, Moshe ^a   Mechta Grigoriou, Fatima ^a  

^a INSTITUT PASTEUR   (France)

^b CENTRE DE BIOCHIMIE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROTECTION; ENZYME ACTIVITY; GENE CONTROL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALIA;

EID: 4544346656     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2004.08.025     Document Type: Article

References (58)

1. Agani F.H., Pichiule P., Chavez J.C., LaManna J.C. The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J. Biol. Chem. 275:2000;35863-35867
2. Arbiser J.L., Petros J., Klafter R., Govindajaran B., McLaughlin E.R., Brown L.F., Cohen C., Moses M., Kilroy S., Arnold R.S., Lambeth J.D. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. USA. 99:2002;715-720
3. Barbacid M. ras genes. Annu. Rev. Biochem. 56:1987;779-827
4. Benjamin L.E., Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors. induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal Proc. Natl. Acad. Sci. USA. 94:1997;8761-8766
5. Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer. 3:2003;401-410
6. Berra E., Benizri E., Ginouves A., Volmat V., Roux D., Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J. 22:2003;4082-4090
7. Bos J.L. ras oncogenes in human cancer. a review Cancer Res. 49:1989;4682-4689
8. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 294:2001;1337-1340
9. Cammack R., Cooper C.E. Electron paramagnetic spectroscopy of iron complexes and iron-containing proteins. Methods Enzymol. 227:1993;353-384
10. Chan D.A., Sutphin P.D., Denko N.C., Giaccia A.J. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 277:2002;40112-40117
11. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA. 95:1998;11715-11720
12. Chen C., Pore N., Behrooz A., Ismail-Beigi F., Maity A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem. 276:2001;9519-9525
13. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:2001;43-54
14. Fandrey J., Genius J. Reactive oxygen species as regulators of oxygen dependent gene expression. Adv. Exp. Med. Biol. 475:2000;153-159
15. Feger F., Ferry-Dumazet H., Mamani Matsuda M., Bordenave J., Dupouy M., Nussler A.K., Arock M., Devevey L., Nafziger J., Guillosson J.J., et al. Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide. Cancer Res. 61:2001;5289-5294
16. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9:2003;669-676
17. Folkman J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82:1990;4-6
18. Giaccia A., Siim B.G., Johnson R.S. HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2:2003;803-811
19. Guichet A., Copeland J.W., Erdelyi M., Hlousek D., Zavorszky P., Ho J., Brown S., Percival-Smith A., Krause H.M., Ephrussi A. The nuclear receptor homologue Ftz-F1 and the homeodomain protein Ftz are mutually dependent cofactors. Nature. 385:1997;548-552
20. Ikeda E., Achen M.G., Breier G., Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270:1995;19761-19766
21. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 275:1997;1649-1652
22. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., Kaelin W.G. Jr. HIFα targeted for VHL-mediated destruction by proline hydroxylation. implications for O2 sensing Science. 292:2001;464-468
23. Jaakkola P., Mole R.D., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Von Kriegsheim A., Hebenstreit H.F., Mukherji M., Schofiels C.J., et al. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292:2001;468-472
24. Kim W., Kaelin W.G. Jr. The von Hippel-Lindau tumor suppressor protein. new insights into oxygen sensing and cancer Curr. Opin. Genet. Dev. 13:2003;55-60
25. Knowles H.J., Raval R.R., Harris A.L., Ratcliffe P.J. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63:2003;1764-1768
26. Kovary K., Bravo R. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11:1991;4466-4472
27. Lallemand D., Spyrou G., Yaniv M., Pfarr C.M. Variations in Jun and Fos protein expression and AP1 activity in cycling, resting, and stimulated fibroblasts. Oncogene. 14:1997;819-830
28. Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 295:2002;858-861
29. Leppa S., Bohmann D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene. 18:1999;6158-6162
30. Li C., Wong W.H. Model-based analysis of oligonucleotide arrays. expression index computation and outlier detection Proc. Natl. Acad. Sci. USA. 98:2001;31-36
31. Liu Q., Berchner-Pannschmidt U., Moller U., Brecht M., Wotzlaw C., Acker H., Jungermann K., Kietzmann T. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc. Natl. Acad. Sci. USA. 101:2004;4302-4307
32. Mahon P.C., Hirota K., Semenza G.L. FIH-1. a novel protein that interacts with HIF-1α and vhl to mediate repression of HIF-1 transcriptional activity Genes Dev. 15:2001;2675-2686
33. Mechta F., Lallemand D., Pfarr C.M., Yaniv M. Transformation by ras modifies AP1 composition and activity. Oncogene. 14:1997;837-847
34. Mechta-Grigoriou F., Gerald D., Yaniv M. The mammalian Jun proteins. redundancy and specificity Oncogene. 20:2001;2378-2389
35. Mitsushita J., Lambeth J.D., Kamata T. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res. 64:2004;3580-3585
36. Peeper D., Upton T., Ladha M., Neuman E., Zalvide J., Bernards R., DeCaprio J., Ewen M. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature. 386:1997;177-181
37. Pfarr C.M., Mechta F., Spyrou G., Lallemand D., Carillo S., Yaniv M. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell. 76:1994;747-760
38. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia. role of the HIF system Nat. Med. 9:2003;677-684. a
39. Pugh C.W., Ratcliffe P.J. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 13:2003;83-89. b
40. 2 levels in fission yeast Schizosaccharomyces pombe. Mol. Biol. Cell. 13:2002;805-816
41. Richard D.E., Berra E., Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J. Biol. Chem. 275:2000;26765-26771
42. Rosche B., Fetzner S., Lingens F., Nitschke W., Riedel A. The 2Fe2S centres of the 2-oxo-1,2-dihydroquinoline 8-monooxygenase from Pseudomonas putida 86 studied by EPR spectroscopy. Biochim. Biophys. Acta. 1252:1995;177-179
43. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15:1999;551-578
44. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:2002;E131-E136
45. Srinivas V., Leshchinsky I., Sang N., King M.P., Minchenko A., Caro J. Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J. Biol. Chem. 276:2001;21995-21998
46. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:1997;269-285
47. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11947-11954
48. Todaro G.J., Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:1963;299-313
49. Townsend D.M., Tew K.D. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 22:2003;7369-7375
50. Ubbink M., Worrall J.A., Canters G.W., Groenen E.J., Huber M. Paramagnetic resonance of biological metal centers. Annu. Rev. Biophys. Biomol. Struct. 31:2002;393-422
51. Vaux E.C., Metzen E., Yeates K.M., Ratcliffe P.J. Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood. 98:2001;296-302
52. Venugopal R., Jaiswal A.K. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene. 17:1998;3145-3156
53. Wagner E.F. AP-1 - Introductory remarks. Oncogene. 20:2001;2334-2335
54. Wang G.L., Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA. 90:1993;4304-4308
55. Wang M.C., Bohmann D., Jasper H. JNK signaling confers tolerance to oxidative stress and extends lifespan in Drosophila. Dev. Cell. 5:2003;811-816
56. Weitzman J.B., Fiette L., Matsuo K., Yaniv M. JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell. 6:2000;1109-1119
57. Wenger R.H. Cellular adaptation to hypoxia. O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression FASEB J. 16:2002;1151-1162
58. Wisdom R., Johnson R.S., Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18:1999;188-197